Related Experiment Video
Updated: Dec 16, 2025

08:27
The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
20.0K
Two Mixed-ligand Coordination Polymers: Crystal Structures and Protective Effect on Ischemic Stroke by Increasing
Xing Fang1, Ke-Zhen Tong2, Xin Wang1
1Department of Neurology, Beilun People's Hospital.
Journal of Oleo Science
|July 3, 2020
Summary
Two novel coordination polymers were synthesized and tested for their potential to treat ischemic stroke in mice. These compounds showed promise in protecting brain cells and improving cognitive function, suggesting therapeutic applications.
Area of Science:
- Materials Chemistry
- Coordination Polymers
- Medicinal Chemistry
Background:
- Mixed-ligand coordination polymers offer tunable properties for various applications.
- Ischemic stroke remains a leading cause of death and disability worldwide.
- Developing novel therapeutic agents for neuroprotection is crucial.
Purpose of the Study:
- To synthesize and characterize two new mixed-ligand coordination polymers using flexible bis-imidazole ligands.
- To evaluate the neuroprotective effects of these compounds in a mouse model of ischemic stroke.
- To investigate the compounds' impact on glucagon-like peptide 1 receptor expression and cognitive function.
Main Methods:
- Solvothermal synthesis of coordination polymers {[Co(bbi)(tdc)]·5H2O}n and {[Cu2(bimb)(H2O)(μ3-tdc)2(DMF)2]·H2O}n.
- Structural characterization using single crystal X-ray diffraction (SXRD), elemental analysis, PXRD, TGA, and IR spectroscopy.
- In vivo evaluation using real-time reverse transcription-polymerase chain reaction (RT-PCR) and the Morris Water Maze experiment.
Main Results:
- Two novel coordination polymers were successfully synthesized and structurally elucidated.
- Compounds 1 and 2 demonstrated protective effects on cerebrovascular endothelial cells.
- Treatment with compounds 1 and 2 modulated glucagon-like peptide 1 receptor expression and improved cognitive function in mice.
Conclusions:
- The synthesized coordination polymers exhibit potential as therapeutic agents for ischemic stroke.
- Further research into their mechanism of action and clinical efficacy is warranted.
- These findings highlight the interdisciplinary potential of coordination chemistry in addressing critical health challenges.
More Related Videos
Related Concept Videos
Glucagon-like Receptor Agonists
720
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
720
Dipeptidyl Peptidase 4 Inhibitors
460
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
460

